Ocular hypertension | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

17,137 results for “Ocular hypertension”

LiGHT Trial Pioneers New Approach to Glaucoma and Ocular Hypertension Management

Ocular Hypertension: Over 60 Companies Advance Clinical Trial Pipeline

China's NMPA Accepts NCX 470 NDA for Review in Open-Angle Glaucoma and Ocular Hypertension

Ocumension Therapeutics Completes Enrollment in Phase III Trial of OT-301 for Glaucoma and Ocular Hypertension

Akums Launches First-in-India Ripasudil-Timolol Combination Eye Drops for Glaucoma Treatment

SpyGlass Pharma's IOL-Mounted Drug Delivery Platform Shows Promising 18-Month Results for Glaucoma Patients

Ocular Therapeutix to Present AXPAXLI Update at J.P. Morgan Healthcare Conference

Gland Pharma Receives US FDA Approval for Latanoprost Ophthalmic Solution

Qlaris Bio Develops Novel Fixed-Dose Combination Therapy Targeting Unaddressed Component of Glaucoma Treatment

Qlaris Bio Appoints Fred Guerard as CEO as QLS-111 Glaucoma Drug Enters Phase 3 Development

Page 1 of 167